Buda Juice (NYSE American: BUDA) reported Q2 2026 revenue of $4.508 million, up 26.4% from $3.567 million, while diluted EPS was $0.04; prior-year EPS was not presented because no common shares were outstanding. Same-store beverage growth and new Walmart and dressings contributions lifted sales, but lower gross margin, higher operating expenses and negative free cash flow limited the benefit.

Core Financial Results

Revenue growth did not translate into higher profit. Gross profit was nearly unchanged as gross margin contracted by 10.1 percentage points, while operating expenses more than doubled to $1.207 million from $0.523 million.

Adjusted EBITDA margin fell to 16.1% from 33.8%, reflecting both cost pressures and investments associated with operating as a public company and supporting expansion.

Adjusted EBITDA and free cash flow are non-GAAP measures. The prior-year results also reflect Buda Juice’s predecessor entity, which was a partnership and did not incur federal corporate income taxes or public-company expenses, limiting the comparability of year-over-year profit figures.

Business and Distribution Performance

The core beverage business delivered same-store sales growth, although Buda did not disclose a Q2 growth rate. Revenue also included partial-quarter contributions from distribution into 246 Walmart locations across nine states and a small cash-funded acquisition of freshly prepared dressings.

Early Q3 results suggest these initiatives continued to contribute. Preliminary, unaudited net sales for the first six weeks of the quarter increased more than 40% year over year. Same-store sales contributed approximately 20 percentage points, with the balance primarily coming from Walmart and dressings.

Buda also cited an early point-of-sale observation from one large retailer where its fresh products occupied about one-third of the juice cooler but may have outsold the adjacent pasteurized juice section. Management emphasized that this was a single early data point rather than a broad retail trend measurement.

Expansion Supported Sales While Transition Costs Pressured Margins

Most of the 10.1-percentage-point gross-margin decline was tied to four identified factors. Temporary third-party co-packing for dressings reduced margin by approximately 320 basis points, elevated lime costs accounted for 290 basis points, unusually high inbound freight contributed 270 basis points and additional training labor added 100 basis points.

Management expects the co-packing pressure to be substantially eliminated when dressings production moves into the Dallas facility in Q1 2027. The company also believes it could eventually pass through elevated freight costs if they persist, but no timing or financial impact was quantified.

Operating expenses created an additional constraint. They rose to 26.8% of revenue from 14.7%, reflecting public-company costs, stock-based compensation, added commercial capabilities for the Walmart expansion and expenses related to the dressings acquisition. With gross profit essentially flat, this higher expense base reduced operating income to $0.444 million. Net interest income of $0.149 million provided a partial offset before taxes.

Cash Flow and Balance Sheet

Q2 free cash flow was negative $0.8 million, compared with positive $0.7 million a year earlier. Buda reported approximately $0.4 million of cash used in operating activities and approximately $0.5 million of total capital expenditures during the quarter, subject to rounding in the company’s reconciliation.

The cash-flow decline primarily reflected a one-time increase in accounts receivable after a major customer moved to non-discounted payment terms, along with approximately $0.4 million spent to upgrade the Dallas facility for dressings production. Management said these factors drove a $1.9 million year-over-year swing in free cash flow and expects the measure to normalize in Q3.

Buda ended June 30 with $18.819 million in cash and no outstanding debt, up from $1.840 million at the end of 2025. The increase mainly reflected financing activity during the first half, including $23.0 million of initial public offering proceeds, less $2.423 million of underwriting and offering costs and a $3.750 million common-stock redemption. Six-month operating cash flow was $0.940 million, down from $1.833 million a year earlier.

Investor Risks to Watch

• Margin recovery depends on execution. Moving dressings production in-house is expected to remove much of the co-packing burden, but the transition is not scheduled until Q1 2027.
• Input and logistics costs remain a source of volatility. Lime prices, inbound freight and training labor accounted for most of the Q2 gross-margin decline. Freight pass-through remains a management expectation rather than a completed action.
• Expansion is raising the operating cost base. Walmart support, the dressings acquisition, public-company expenses and stock-based compensation increased operating costs faster than revenue in Q2.
• Cash conversion has weakened. Higher accounts receivable and facility spending turned free cash flow negative. Management expects normalization in Q3, but the reported improvement has not yet occurred.
• Early Q3 figures are preliminary. The more-than-40% sales increase covers only the first six weeks, remains unaudited and is not full-quarter guidance.

Summary

Buda Juice expanded revenue through same-store beverage growth, Walmart distribution and its entry into fresh dressings, but those initiatives came with transition costs and higher operating expenses that sharply reduced profitability. The debt-free balance sheet provides liquidity for the expansion, while margin recovery, cash-flow normalization and the durability of early Q3 sales growth are the main items to monitor.

Find out more